Mississippi PSE Prescription Switch Will Not Start An Avalanche - CHPA
This article was originally published in The Tan Sheet
Executive Summary
Mississippi lawmakers' decision to make all pseudoephedrine-containing drugs prescription-only will not prompt other states combating methamphetamine to do the same, the Consumer Healthcare Products Association predicts
You may also be interested in...
Pseudoephedrine Tide Turns: Nonprescription Sales Return In Mississippi, Oregon Mulls Change
Mississippi repeals prescription requirement for all pseudoephedrine- and ephedrine-containing drugs while also requiring retailer participation in industry-funded technology for tracking drug sales. Oregon, the only other state with PSE Rx law, is considering repealing it.
Rx-Only Pseudoephedrine Stalls As Meth Solution In Tennessee, Indiana
Tennessee’s meth lab seizures are up this year, but CHPA says that’s because more labs are uncovered through the state’s participation in the NPLEx stop-sale system. Rx-only bills have stalled in several states, including Indiana, where lawmakers passed a bill to cap PSE purchases at about 61 grams per year.
Rx-Only Pseudoephedrine Stalls As Meth Solution In Tennessee, Indiana
Tennessee’s meth lab seizures are up this year, but CHPA says that’s because more labs are uncovered through the state’s participation in the NPLEx stop-sale system. Rx-only bills have stalled in several states, including Indiana, where lawmakers passed a bill to cap PSE purchases at about 61 grams per year.